Intolerance of sublingual buprenorphine-naloxone during induction in a patient with end-stage liver disease: A case report

INTRODUCTION: Sublingual buprenorphine is indicated for opioid dependence. It comes in 2 formulations: a mono buprenorphine product (BUP) and a combination product containing naloxone (BUP-NAL), which functions as an abuse deterrent. Sublingual naloxone does not reach clinically significant levels e...

Descripción completa

Detalles Bibliográficos
Autores principales: Behan, Jennifer, Geier, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2016
Materias:
Addictive Disorder Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007647/
https://www.ncbi.nlm.nih.gov/pubmed/29955460
http://dx.doi.org/10.9740/mhc.2016.05.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007647/
https://www.ncbi.nlm.nih.gov/pubmed/29955460
http://dx.doi.org/10.9740/mhc.2016.05.131

Ejemplares similares